Skip to main navigation Skip to search Skip to main content

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1

  • Ira Jacobson*
  • , Stefan Zeuzem
  • , Robert Flisiak
  • , Brygida Knysz
  • , Stefan Lueth
  • , Dorota Zarebska-Michaluk
  • , Ewa Janczewska
  • , Peter Ferenci
  • , Moises Diago
  • , Anna Linda Zignego
  • , Rifaat Safadi
  • , Yaacov Baruch
  • , Djamal T. Abdurakhmanov
  • , Stephen Shafran
  • , Dominique Thabut
  • , Rafael Bruck
  • , Adrian Gadano
  • , Alexander James Thompson
  • , Justin Kopit
  • , Fiona McPhee
  • Tracy Michener, Eric A. Hughes, Philip D. Yin, Stephanie Noviello
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science